2007
DOI: 10.1016/j.biomaterials.2006.12.028
|View full text |Cite
|
Sign up to set email alerts
|

The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres

Abstract: It is advantageous to incorporate controlled growth factor delivery into tissue engineering strategies. The objective of this study was to develop a three-dimensional (3D) porous tissue engineering scaffold with the capability of controlled releasing recombinant human bone morphogenetic protein-7 (rhBMP-7) for enhancement of bone regeneration. RhBMP-7 was first encapsulated into poly(lactic-co-glycolic acid) (PLGA) nanospheres (NS) with an average diameter of 300 nm. Poly (L-lactic acid) (PLLA) scaffolds with … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
230
0

Year Published

2008
2008
2021
2021

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 268 publications
(235 citation statements)
references
References 47 publications
3
230
0
Order By: Relevance
“…Four scaffolds (without cells) were implanted subcutaneously onto the dorsum of each rat. After 6 weeks, H & E staining indicates that there was significant bone formation in the BMP7-NS containing scaffold (Figure 11 A), but only fibrous tissue in the scaffold without BMP7 (Figure 11 B), or in the same scaffold pre-soaked in a BMP7 solution (Figure 11 C) [140]. This result was also supported by von Kossa staining and radiographic measurements [140].…”
Section: Bioactive Molecule Deliverymentioning
confidence: 71%
See 2 more Smart Citations
“…Four scaffolds (without cells) were implanted subcutaneously onto the dorsum of each rat. After 6 weeks, H & E staining indicates that there was significant bone formation in the BMP7-NS containing scaffold (Figure 11 A), but only fibrous tissue in the scaffold without BMP7 (Figure 11 B), or in the same scaffold pre-soaked in a BMP7 solution (Figure 11 C) [140]. This result was also supported by von Kossa staining and radiographic measurements [140].…”
Section: Bioactive Molecule Deliverymentioning
confidence: 71%
“…We have recently developed technologies to immobilize nano-spheres onto the pore surface of scaffolds, such as the macro-porous and nano-fibrous scaffolds [140,141]. Single or multiple biological factors can be released in a spatially and temporally controlled fashion ( Figure 9).…”
Section: Bioactive Molecule Deliverymentioning
confidence: 99%
See 1 more Smart Citation
“…In fact, as we have observed the silk fibroin microparticles exhibited a slow rate of degradation. The release amounts during this phase were such that they could meet the concentrations of growth factor required in most in vitro and in vivo applications (in the range of few hundreds of nanograms to a few micrograms), by choosing a specific amount of BMP during the loading process (Kenley et al, 1994;Hosseinkhani et al, 2007;Wei et al, 2007;Bessa et al, 2009).…”
Section: Discussionmentioning
confidence: 99%
“…Several different microparticulated systems have been investigated for the delivery of BMPs, most based on polylactic-co-glycolic acid (PLGA) (Lee et al, 1994;Phillips et al, 2006;Wei et al, 2007), on collagen (Wang et al, 2003, Itoh et al, 2004 or on dextran (Chen et al, 2006. Silk is an attractive choice as a material for bone tissue engineering, due to being biocompatible, slowly biodegradable and possessing excellent mechanical properties such as tensile strength and rigidity which are highly desirable for a potential use as a scaffold for bone tissue engineering (Scheibel 2006).…”
Section: Introductionmentioning
confidence: 99%